Abstract #1408162: Comparison of Different Doses of Sodium-Glucose Ttransporter-2 Inhibitors (SGLT2i) to SGLT2i with Magnesium Infusions for Refractory Hypomagnesaemia in a Patient with Monogenic Diabetes Type-5 (MODY-5)
نویسندگان
چکیده
MODY-5 is a rare autosomal dominant form of monogenic diabetes attributed to deletions chromosome 17q12 with impaired expression HNF1β (Hepatocyte Nuclear Factor 1 homeobox Beta. The deficient HNF1B down regulated the FXYD2. Refractory hypomagnesemia commonly observed in patients due downregulated FXYD2 which blocked encoding γ (gamma) subunit Na+-K+-ATPase and indirectly led hypomagnesemia. SGLT2i have been associated small but significant increases serum magnesium (sMg) levels diabetes. We report our patient's experience comparing use at different doses Mg infusions for refractory patient MODY-5. 29 y/o Caucasian female family history young onset was diagnosed age 19 years old when she found kidney cysts that were noted incidentally on MRI spine. She presents clinic hypertension, catamenial headaches, hyperuricemia, oral supplements (400mg twice day) wasting syndrome, congenital pancreatic atresia exocrine insufficiency. sMg <1.0mg/dl 2 symptomatic it such as fatigue, headaches muscle aches. Most lately, could not tolerate more than 1000mg day diarrhea. Prior starting her fractional excretion (FEMg) 14.5% (normal FEMg <4% setting hypomagnesemia). started canagliflozin 100mg titrated 300mg; has improved level from 0.9 mg/dl 1.2mg/dl stable this dose weeks. data available change canagliflozin. also amiloride 5mg daily. dropped <1 md/dL stopped insurance again after empagliflozin. On 10mg empagliflozin compared 25mg changed remained 1.1mg/dl 10% 7.25%. continued symptoms hypomagnesemia, so sulfate 2gm 100ml normal saline infused over 12hrs 3 times week 6 months. Her infusion, they wear off quickly. Magnesium 1.5mg/dl 12.6%. Did improve. Lately treatment burden decreased per week. improve syndrome. >1 mg/dL SGLT2i. There no difference low versus high empagliflozin, an improvement FEMg. Adding infusion slightly sMg, expense disease treatment.
منابع مشابه
a comparison of teachers and supervisors, with respect to teacher efficacy and reflection
supervisors play an undeniable role in training teachers, before starting their professional experience by preparing them, at the initial years of their teaching by checking their work within the proper framework, and later on during their teaching by assessing their progress. but surprisingly, exploring their attributes, professional demands, and qualifications has remained a neglected theme i...
15 صفحه اولprevalence of atopic dermatitis in children with type 1 diabetes mellitus in southeastern of iran (kerman province): a case-control study
چکیده ندارد.
15 صفحه اولa new type-ii fuzzy logic based controller for non-linear dynamical systems with application to 3-psp parallel robot
abstract type-ii fuzzy logic has shown its superiority over traditional fuzzy logic when dealing with uncertainty. type-ii fuzzy logic controllers are however newer and more promising approaches that have been recently applied to various fields due to their significant contribution especially when the noise (as an important instance of uncertainty) emerges. during the design of type- i fuz...
15 صفحه اولthe past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Impact of Sodium‐Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes
The efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitors canagliflozin, dapagliflozin, and empagliflozin in reducing hyperglycemia in patients with type 2 diabetes is well documented. In addition, positive effects have been observed with these agents on nonglycemic variables, such as reductions in body weight and blood pressure, which may confer additional health benefits. SGLT2 in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Endocrine Practice
سال: 2023
ISSN: ['1530-891X', '1934-2403']
DOI: https://doi.org/10.1016/j.eprac.2023.03.100